CLINICAL AND PARACLINICAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH INFECTION
Main Article Content
Abstract
Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, with a rising prevalence in developing countries. Infection represents a major determinant of increased hospitalization and suboptimal therapeutic outcomes in IBD. We conducted a cross-sectional study involving 62 infected and 169 non-infected patients at Hanoi Medical University Hospital and Bach Mai Hospital. The cohort was predominantly male (55%), with 10,4% aged over 65 years, and a mean hospital stay of 14,5 ± 8,2 days. The most common gastrointestinal infection in both Crohn’s disease and ulcerative colitis was observed at rates of 22,5% and 26,1%, respectively, with the predominant clinical manifestations being fever (100%) and abdominal pain (71%). Infection was most frequent in severe disease (33,3%) and strongly associated with TNF-α inhibitors or combination therapy. Infected patients showed elevated leukocyte count, ESR, hs-CRP, and PCT compared with non-infected cases.
Article Details
Keywords
Inflammatory Bowel Disease; Infection; Immunosuppressive therapy
References
2. Irving PM, de Lusignan S, Tang D, Nijher M, Barrett K. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterol. 2021;8(1):e000573. doi:10.1136/ bmjgast-2020-000573
3. Trần Ngọc Ánh. Cấp Cứu Nội Tiêu Hóa.; 2021. https://thuvien.hmu.edu.vn/pages/cms/FullBookReader.aspx?Url=/pages/cms/TempDir/books/202306091537-865727e4-cdfb-44cf-920c-ce864fcbcf31//FullPreview&TotalPage=427&ext=jpg#page/1/mode/2up
4. Delévaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62(4):337-340. doi:10.1136/ard.62.4.337
5. Kucharzik T, Ellul P, Greuter T, et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis. 2021;15(6):879-913. doi:10.1093/ecco-jcc/jjab052
6. Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023; 13(3):e065186. doi:10.1136/bmjopen-2022-065186
7. Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries. Gastroenterology. 2018;155(4):1079-1089.e3. doi:10.1053/j.gastro.2018.06.043
8. Chung SH, Lee HW, Kim SW, et al. Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease. Gut Liver. 2016;10(4):574-580. doi:10.5009/gnl15209
9. Risk of bacteremia in hospitalised patients with inflammatory bowel disease: A 9-year cohort study. doi:10.1177/2050640619874524
10. Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2018;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012